Results 31 to 40 of about 2,002 (144)

Challenging diagnosis of indolent systemic mastocytosis isolated to the GI tract. [PDF]

BMJ Case Rep, 2021
Mastocytosis is a rare group of disorders that presents with heterogenous phenotypes depending on the organ system involved. In the absence of cutaneous involvement—mast cell aggregates that may present as papules, nodules or plaques—classically associated with indolent systemic mastocytosis (SM), the diagnosis of this rare condition is particularly ...
Horton L, Al-Kourainy N, Kabbani D, Bishop CR.   +3 more
europepmc   +3 more sources

Indolent Systemic Mastocytosis: An Incidental Diagnosis

Annals of Internal Medicine: Clinical Cases
Indolent systemic mastocytosis (ISM) is the most prevalent subtype of systemic mastocytosis, characterized by a clinical course progressing over several years to decades.
Ayesha Khalid, Arfa Faiz, Alan Kaell
doaj   +2 more sources

Pancreatic neuroendocrine tumor presenting in indolent systemic mastocytosis: A case report. [PDF]

Int J Surg Case Rep, 2020
Abstract Introduction Systemic mastocystosis, a disorder of clonal mast cell expansion presents with symptoms of flushing, pruritus, musculoskeletal pain, gastrointestinal cramping and vascular instability. Patients with neuroendocrine tumors may present with similar symptoms due to the release
Sacco K, Khan TM, Passi M, Hernandez JM, Komarow H.   +4 more
europepmc   +3 more sources

Indolent Systemic Mastocytosis Manifesting as Protracted Anaphylactic Shock.

Indian J Crit Care Med, 2018
Systemic mastocytosis is a rare disease due to abnormal proliferation of mast cells (MCs). A case of indolent systemic mastocytosis is presented here. After anesthetic induction for elective thyroid swelling with propofol and atracurium followed by endotracheal intubation, a 57-year-old female patient developed acute hypotension, sinus tachycardia, red
Chatterjee M, Sengupta S, Chakravarty C, Ramasubban S, Bhartia S, Khan S, Agarwal VK.   +6 more
europepmc   +3 more sources

Indolent systemic mastocytosis and aleukemic mast cell leukemia: Subtle diagnostic differences with distinct management approaches [PDF]

JAAD Case Reports, 2023
Sara Yumeen, Elie Saliba
exaly   +2 more sources

Remission of indolent systemic mastocytosis in the absence of targeted therapy. [PDF]

J Allergy Clin Immunol Pract, 2022
Constantine GM, Metcalfe DD, Akin C, Sun X, Bai Y, Eisch AR, Maric I, Komarow HD.   +7 more
europepmc   +3 more sources

Indolent systemic mastocytosis in a child: A rare and difficult diagnosis

Indian Journal of Paediatric Dermatology, 2016
Mastocytosis is a sporadic disease characterized by an abnormal accumulation of mast cells (MCs) in single or multiple organs. A 5-year-old girl who was diagnosed as cutaneous mastocytosis by our Dermatology Department when she was 4 months of age was ...
Yasemin Altuner Torun, Ayse Betul Ergul, Elif Guler Kazancı, Mahmut Can Serbetci, Fatma Mutlu Sarıguzel   +4 more
doaj   +2 more sources

Avapritinib versus Placebo in Indolent Systemic Mastocytosis [PDF]

NEJM Evidence, 2023
BACKGROUND: Indolent systemic mastocytosis (ISM) is a clonal mast-cell disease driven by the KIT D816V mutation. We assessed the efficacy and safety of avapritinib versus placebo, both with best supportive care, in patients with ISM. METHODS: We randomized patients with moderate to severe ISM (total symptom score [TSS] of ≥28; scores range from 0 to ...
van Daele, Paul, Gotlib, Jason, Castells, Mariana, Oude Elberink, J. Hanneke N.G., Siebenhaar, Frank, Hartmann, Karin, Broesby-Olsen, Sigurd, George, Tracy I., Panse, Jens, Alvarez-Twose, I, Radia, Deepti H., Tashi, Tsewang, Livideanu, Cristina Bulai, Sabato, Vito, Heaney, Mark, van Daele, Paul, Cerquozzi, Sonia, Dybedal, Ingunn, Reiter, Andreas, Pongdee, Thanai, Barete, Stephane, Ustun, Celalettin, Schwarts, Lawrence, Ward, Brant R., Schafhausen, Philippe, Vadas, Peter, Bose, Prithviraj, DeAngelo, Daniel J., Rein, Lindsay, Vachhani, Pankit, Triggiani, Massimo, Bonadonna, Patrizia, Rafferty, Mark, Butt, Nauman M., Oh, Stephen T., Wortmann, Friederike, Ungerstedt, Johanna, Guilarte, Mar, Taparia, Minakshi, Kuykendall, Andrew T., Yi, Cecilia Arana, Ogbugo, Princess, Gaudy-Marqueste, Caroline, Mattson, Mattias, Shomali, William, Giannetti, Matthew P., Bidollari, Ilda, Lin, Hui-Min, Sullivan, Erin, Mar, Brenton, Scherber, Robyn, Roche, Maria, Akin, Cem, Maurer, Marcus   +53 more
openaire   +5 more sources

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification [PDF]

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová   +2 more
exaly   +2 more sources

Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms [PDF]

Frontiers in Allergy
Matthew J Hamilton, Lauren M Madigan, Sa A Wang   +2 more
exaly   +2 more sources